Typical Price is the average of the high, low, and close, providing a balanced view of intraday price action.
Day Typical Price Analysis Today
Typical Price is the average of the high, low, and close, providing a balanced view of intraday price action. The current Day Typical Price for Revelation Biosciences is 0.98. This reading indicates consistent price behavior relative to the prior session.
On May 10 2026 Revelation Biosciences was traded for 0.96 at the closing time. The top price for the day was 1.02 and the lowest listed price was 0.95 . Trading activity remained within a narrow range during the period. Price movement on May 10, 2026 remained within defined bounds. The trading delta at closing time against the current closing price is 4.17% .
By including the close alongside the high-low range, Typical Price gives more weight to the settlement level than Median Price does. It is frequently used as an input for volume-weighted indicators and pivot point calculations.
Related Price-Series Methods for Revelation Biosciences
These methods summarize the same price history through smoothing, range, and momentum calculations. Reviewing them alongside Day Typical Price helps compare stable sessions with periods of wider price movement in Revelation Biosciences.
Checking Revelation Biosciences against related firms within the Health Care space reveals where the stock stands among peers. Key comparison metrics include price-to-earnings, profit margin, and revenue growth across Revelation Biosciences' peer group. Persistent outperformance or underperformance by specific peers relative to Revelation Biosciences often signals structural advantages or weaknesses.
For investors tracking Revelation Biosciences, market strength indicators offer quantitative evaluation of stock behavior. When Rate of Change diverges from price direction, it often signals weakening momentum before a visible reversal in Revelation Biosciences.
Analyzing Revelation Biosciences' basic risk indicators provides a structured view of the risk-return trade-off for revelation stock. Expected shortfall estimates the average loss in the worst-case tail scenarios, going beyond what standard deviation alone captures for Revelation Biosciences.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Revelation Biosciences Short Properties
Reviewing short-oriented indicators for Revelation Biosciences is useful because long and short participants often create very different signals for timing and volatility. Comparing short sentiment with trend behavior, volume, and the broader market narrative provides a more grounded view.
Common Stock Shares Outstanding
620,800
Cash And Short Term Investments
10.7 million
More Resources for Revelation Stock Analysis
The foundation for reviewing Revelation Biosciences is its financial reporting and trend data. The data captures Revelation Biosciences' financial activity across reporting cycles.